Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
Evaluation of the SMART IBD App in Pediatric IBD
for
Inflammatory Bowel Disease (IBD),
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 13 - 17
Code: NCT07195123
Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Cincinnati OH, Ann Arbor MI, Chicago IL, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase 2, Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
for
Pneumococcal Disease
Location: Cincinnati OH, Dayton OH, Bardstown KY, South Euclid OH,
Location: Cincinnati OH, Columbus OH, Ann Arbor MI,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT06838676
Phase 2, Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
for
Heterozygous Familial Hypercholesterolemia (HeFH)
Location: Cincinnati OH, Morgantown WV, St Louis MO, Atlanta GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 6 - 17
Code: NCT07058077
Phase 2, Phase 3, Recruiting
Bowel Continence Across the Lifespan in People With Spina Bifida
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia